oral semaglutide launch Hims & Hers copies Novo Nordisk's new Wegovy pill Dr Reddy's Laboratories launches semaglutide

Cancer Risk Malignant neoplasm rates in clinical trials were similar between semaglutide and comparator groups, providing reassurance regarding cancer risk in humans despite thyroid findings in rodent studies

Silber JJ, Biasutti A, Abuin E, Lissi E

We are committed to helping you achieve your health and wellness goals with the highest standard of care

Some individuals also experience gastrointestinal side effectssuch as nausea, bloating, or diarrhoeawhich may be exacerbated by consuming high-fat foods like ice cream, particularly in the early weeks of treatment or after dose escalation

Treatment may continue with doctors increasing the dosage by 0.5 mg each week